Stock Scorer

Omega Healthcare Investors Inc (OHI) · Insider trading

What Omega Healthcare Investors's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$1.36M
2 insiders, 2 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$1.36M
bought less sold
Latest filing
2026-10-01
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2025-08: $100,400 sold 2025-11: $1.36M bought 2026-01 2026-07
Bought Sold Largest month: $1.36M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Pickett C TaylorDirector, CHIEF EXECUTIVE OFFICER $862,800 – 1 2025-11-05 –
Gupta VikasChief Investment Officer $494,155 – 1 2025-11-06 13,773
Egbuonu-Davis LisaDirector – $100,400 2 2025-08-08 20,954

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2025-11-06 Gupta VikasChief Investment Officer Buy 11,500 42.97 $494,155 13,773 Form 4
2025-11-05 Pickett C TaylorDirector, CHIEF EXECUTIVE OFFICER Buyindirect 20,000 43.14 $862,800 20,000 Form 4
2025-08-08 Egbuonu-Davis LisaDirector Sale 200 40.16 $8,032 20,954 Form 4
2025-08-08 Egbuonu-Davis LisaDirector Sale 2,300 40.16 $92,368 18,654 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

16 × grant or award7 × shares withheld for tax5 × gift3 × returned to the company
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-10-01 Golem Lucas M.CHIEF ACCOUNTING OFFICER Grant or award A +64 39.37 1,770 Form 4
2026-10-01 Golem Lucas M.CHIEF ACCOUNTING OFFICER Returned to the company D −3 46.31 1,767 Form 4
2026-08-07 Egbuonu-Davis LisaDirector Gift G −5,131 – 17,301 Form 4
2026-07-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +168 37.25 4,676 Form 4
2026-07-01 Ballew NealCHIEF ACCOUNTING OFFICER Returned to the company D −11 47.68 4,665 Form 4
2026-06-05 Whitman Burke WDirector Grant or award A +3,778 43.67 47,931 Form 4
2026-06-05 Jacobs Kevin JDirector Grant or award A +6,125 43.67 46,935 Form 4
2026-06-05 Egbuonu-Davis LisaDirector Grant or award A +3,778 43.67 22,432 Form 4
2026-04-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +168 37.25 4,516 Form 4
2026-04-01 Ballew NealCHIEF ACCOUNTING OFFICER Returned to the company D −8 43.82 4,508 Form 4
2026-01-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +173 35.89 4,360 Form 4
2026-01-01 Ballew NealCHIEF ACCOUNTING OFFICER Shares withheld for tax F −12 44.34 4,348 Form 4
2025-12-31 Stephenson Robert OCHIEF FINANCIAL OFFICER Gift G −31,426 – 147,000 Form 4
2025-12-31 Stephenson Robert OCHIEF FINANCIAL OFFICER Gift G +31,426 – 31,426 Form 4
2025-12-30 Stephenson Robert OCHIEF FINANCIAL OFFICER Gift G −3,850 – 178,426 Form 4
2025-10-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +201 31.16 4,204 Form 4
2025-10-01 Ballew NealCHIEF ACCOUNTING OFFICER Shares withheld for tax F −17 42.22 4,187 Form 4
2025-08-26 Stephenson Robert OCHIEF FINANCIAL OFFICER Gift G −800 – 182,276 Form 4
2025-07-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +200 31.16 4,012 Form 4
2025-07-01 Ballew NealCHIEF ACCOUNTING OFFICER Shares withheld for tax F −9 36.65 4,003 Form 4
2025-06-06 Egbuonu-Davis LisaDirector Grant or award A +4,388 37.60 21,154 Form 4
2025-06-06 Jacobs Kevin JDirector Grant or award A +7,114 37.60 40,810 Form 4
2025-06-06 Whitman Burke WDirector Grant or award A +4,388 37.60 44,153 Form 4
2025-04-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +195 32.18 3,821 Form 4
2025-04-01 Ballew NealCHIEF ACCOUNTING OFFICER Shares withheld for tax F −9 38.08 3,812 Form 4
2025-01-01 Gourmand Matthew PaulPresident Grant or award A +174 32.18 1,076 Form 4
2025-01-01 Gourmand Matthew PaulPresident Shares withheld for tax F −9 37.85 1,067 Form 4
2025-01-01 Gupta VikasChief Investment Officer Grant or award A +192 32.18 2,283 Form 4
2025-01-01 Gupta VikasChief Investment Officer Shares withheld for tax F −10 37.85 2,273 Form 4
2025-01-01 Ballew NealCHIEF ACCOUNTING OFFICER Grant or award A +193 32.18 3,636 Form 4
2025-01-01 Ballew NealCHIEF ACCOUNTING OFFICER Shares withheld for tax F −10 37.85 3,626 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Omega Healthcare Investors's scores and multiples ›